UK markets closed

Beam Therapeutics Inc. (BEAM)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
25.93-1.34 (-4.91%)
At close: 04:00PM EDT
26.00 +0.07 (+0.27%)
After hours: 07:01PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts12121413
Avg. Estimate-1.42-1.38-5.38-5.07
Low estimate-2.16-2.19-8.85-5.85
High estimate-1.18-1.18-4.51-3.47
Year ago EPS-1.33-1.08-1.72-5.38
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts11111412
Avg. Estimate16.97M15.2M63.42M64.3M
Low estimateN/AN/AN/AN/A
High estimate40M20.71M100M110M
Year ago sales24.21M20.12M377.71M63.42M
Sales growth (year/est)-29.90%-24.40%-83.20%1.40%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-1.34-1.42-1.36-1.01
Actual EPS-1.33-1.08-1.221.73
Difference0.010.340.142.74
Surprise %0.70%23.90%10.30%271.30%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-1.42-1.38-5.38-5.07
7 days ago-1.42-1.38-5.38-5.07
30 days ago-1.39-1.36-5.31-5.05
60 days ago-1.16-1.15-4.6-4.37
90 days ago-1.15-1.14-4.62-4.39
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/A1
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesBEAMIndustrySector(s)S&P 500
Current qtr.-6.80%N/AN/AN/A
Next qtr.-27.80%N/AN/AN/A
Current year-212.80%N/AN/AN/A
Next year5.80%N/AN/AN/A
Next 5 years (per annum)-3.70%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A